BG101408A - Аналози на кератиноцитния растежен фактор - Google Patents

Аналози на кератиноцитния растежен фактор

Info

Publication number
BG101408A
BG101408A BG101408A BG10140897A BG101408A BG 101408 A BG101408 A BG 101408A BG 101408 A BG101408 A BG 101408A BG 10140897 A BG10140897 A BG 10140897A BG 101408 A BG101408 A BG 101408A
Authority
BG
Bulgaria
Prior art keywords
growth factor
kgf
keratinotine
analysis
epithelial cell
Prior art date
Application number
BG101408A
Other languages
English (en)
Other versions
BG63167B1 (bg
Inventor
Charles Morris
William Kenney
Bao-Lu Chen
Erik Hsu
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of BG101408A publication Critical patent/BG101408A/bg
Publication of BG63167B1 publication Critical patent/BG63167B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до аналози на силен митоген на растежа на нефибробластни епителни клетки, кератиноцитен растежен фактор (KGF), модифициран допървите 24 N-крайни аминокиселини, където цистеиновите остатъци, съответстващи на позициите на аминокиселини 1 и 15 на KGF [позиции 32 и 46 на аминокиселини от SEQ ID NO:2, (съответно Cys1 и Cys15)],са заличени или заместени с друга аминокиселина. Изобретението се отнася и до молекули на нуклеинови киселини, които кодират такива аналози, и до методи за използването на такива аналози за стимулиране пролиферацията на нефибробластни епителни клетки.
BG101408A 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор BG63167B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32347594A 1994-10-13 1994-10-13
US32334094A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/IB1995/000971 WO1996011949A2 (en) 1994-10-13 1995-10-12 Analogs of keratinocyte growth factor

Publications (2)

Publication Number Publication Date
BG101408A true BG101408A (bg) 1997-12-30
BG63167B1 BG63167B1 (bg) 2001-05-31

Family

ID=27406268

Family Applications (2)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор
BG101408A BG63167B1 (bg) 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор

Country Status (23)

Country Link
EP (2) EP0785948B1 (bg)
JP (2) JP4216329B2 (bg)
KR (1) KR100278597B1 (bg)
CN (1) CN1168678A (bg)
AT (2) ATE342278T1 (bg)
AU (1) AU3707795A (bg)
BG (2) BG101392A (bg)
BR (2) BR9509269A (bg)
CA (2) CA2202075C (bg)
CZ (3) CZ297329B6 (bg)
DE (2) DE69530403T2 (bg)
DK (2) DK0804479T3 (bg)
EE (2) EE03975B1 (bg)
ES (2) ES2196082T3 (bg)
FI (2) FI971420A0 (bg)
HU (2) HUT78050A (bg)
NO (2) NO971566L (bg)
NZ (2) NZ505502A (bg)
PL (2) PL182888B1 (bg)
PT (2) PT785948E (bg)
SI (2) SI0785948T1 (bg)
SK (2) SK284534B6 (bg)
WO (2) WO1996011949A2 (bg)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153816T3 (es) 1989-01-31 2001-03-16 Jeffrey S Rubin Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
KR960703433A (ko) 1993-06-29 1996-08-17 로버트 피. 블랙버언 증가된 생물학적 활성을 갖는 끝이 잘린 케라틴세포성장인자(kgf) (a truncated keratinocyte growth factor(kgf) having increased biological activity)
IL115605A (en) * 1994-10-13 2003-06-24 Amgen Inc Method for purifying keratinocyte growth factors
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
DE69603269T3 (de) * 1995-04-27 2007-02-22 Coöperatie Cosun U.A. Derivate von inulin
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
DK0935652T3 (da) * 1996-10-15 2004-07-26 Amgen Inc Keratinocyt vækstfaktor-2 produkter
EP1473366A1 (en) * 1996-10-15 2004-11-03 Amgen Inc. Keratinocyte growth factor-2 products
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
WO1999032135A1 (en) 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6242666B1 (en) * 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
BR122013003013B8 (pt) * 1999-01-14 2021-07-06 Bolder Biotechnology Inc proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
CA2437270A1 (en) * 2001-02-06 2002-08-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Modified keratinocyte growth factor (kgf) with reduced immunogenicity
JP2005500390A (ja) 2001-08-21 2005-01-06 カイロン コーポレイション Ｋｇｆポリペプチド組成物
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
US8304387B2 (en) 2004-12-15 2012-11-06 Swedish Orphan Biovitrum Ab (Publ) Therapeutic formulations of keratinocyte growth factor
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5145225A (en) * 1988-07-27 1992-09-08 Muller George M Carpet stretcher
ES2153816T3 (es) * 1989-01-31 2001-03-16 Jeffrey S Rubin Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
JP3578761B2 (ja) * 1993-03-26 2004-10-20 アムジエン・インコーポレーテツド 表皮ケラチン細胞成長因子の治療目的での使用
US5348563A (en) * 1993-06-29 1994-09-20 Honeywell Inc. Air purifying apparatus
KR960703433A (ko) * 1993-06-29 1996-08-17 로버트 피. 블랙버언 증가된 생물학적 활성을 갖는 끝이 잘린 케라틴세포성장인자(kgf) (a truncated keratinocyte growth factor(kgf) having increased biological activity)
GB9315501D0 (en) * 1993-07-27 1993-09-08 Ici Plc Surfactant compositions
AU7475694A (en) * 1993-08-02 1995-02-28 Prizm Pharmaceuticals, Inc. Monogenous preparations of cytotoxic conjugates

Also Published As

Publication number Publication date
SK43197A3 (en) 1999-03-12
CA2201940C (en) 2009-05-12
PL182888B1 (pl) 2002-03-29
FI971420A7 (fi) 1997-04-04
NO971566D0 (no) 1997-04-04
SK45597A3 (en) 1999-02-11
EP0785948A1 (en) 1997-07-30
JP4216329B2 (ja) 2009-01-28
FI971536L (fi) 1997-06-09
WO1996011949A3 (en) 1996-12-12
BG63167B1 (bg) 2001-05-31
CZ297328B6 (cs) 2006-11-15
AU681546B2 (en) 1997-08-28
FI971536A0 (fi) 1997-04-11
AU3708395A (en) 1996-05-06
DE69535264T2 (de) 2007-02-01
JPH10507080A (ja) 1998-07-14
FI120040B (fi) 2009-06-15
BR9509269A (pt) 1997-12-23
BR9509329A (pt) 1997-10-14
SI0785948T1 (en) 2003-08-31
NZ335109A (en) 2000-08-25
CZ297329B6 (cs) 2006-11-15
FI971420L (fi) 1997-04-04
EE9700081A (et) 1997-10-15
HUT78058A (hu) 1999-07-28
ATE237633T1 (de) 2003-05-15
CZ98197A3 (cs) 1998-11-11
NO971568D0 (no) 1997-04-04
CA2202075C (en) 2003-12-09
KR100278597B1 (ko) 2001-01-15
EP0785948B1 (en) 2003-04-16
DK0804479T3 (da) 2007-01-29
DE69530403T2 (de) 2003-10-30
WO1996011949A2 (en) 1996-04-25
PL319784A1 (en) 1997-08-18
EP0804479A1 (en) 1997-11-05
ES2196082T3 (es) 2003-12-16
EE9700225A (et) 1998-02-16
DK0785948T3 (da) 2003-08-04
HUT78050A (hu) 1999-07-28
HU226168B1 (en) 2008-05-28
JP4426646B2 (ja) 2010-03-03
CA2202075A1 (en) 1996-04-25
EP0804479B1 (en) 2006-10-11
WO1996011950A1 (en) 1996-04-25
JPH10507193A (ja) 1998-07-14
DE69535264D1 (de) 2006-11-23
AU3707795A (en) 1996-05-06
ATE342278T1 (de) 2006-11-15
EE03975B1 (et) 2003-02-17
PT785948E (pt) 2003-09-30
SK284534B6 (sk) 2005-06-02
NO971568L (no) 1997-06-12
NO318761B1 (no) 2005-05-02
PT804479E (pt) 2007-02-28
FI971420A0 (fi) 1997-04-04
BG101392A (bg) 1997-10-31
SI0804479T1 (sl) 2006-12-31
NO971566L (no) 1997-04-14
CA2201940A1 (en) 1996-04-25
ES2273338T3 (es) 2007-05-01
CZ105097A3 (cs) 1998-10-14
PL320484A1 (en) 1997-09-29
NZ505502A (en) 2005-01-28
DE69530403D1 (de) 2003-05-22
CN1168678A (zh) 1997-12-24

Similar Documents

Publication Publication Date Title
BG101408A (bg) Аналози на кератиноцитния растежен фактор
KR880010130A (ko) 폴리 펩티드, dna 및 그의 용도
BR9712077A (pt) Expressão de proteìnas de alto nìvel
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
ATE310015T1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
ATE272109T1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
PT785950E (pt) Analogos do factor de crescimento de queratinocitos
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
EP0546074A4 (en) Genetic material encoding igfbp-5
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
NO930428L (no) Proteinstrukturen til plantetoksingelonin
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE69031726D1 (de) Antikörper, ihre Herstellung und Verwendung
DE69737476D1 (de) Neuer galaninrezeptor
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
DE59207008D1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
NZ606260A (en) Novel polypeptides involved in immune response